Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Colonic Neoplasms 3Urinary Bladder Neoplasms 2Pain 2Breakthrough Cancer Pain 2Agnosia 2Rectal Neoplasms 1Postoperative Cognitive Complications 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Pain, Postoperative 1Neoplasms 1Nasopharyngeal Carcinoma 1Intrathecal Dexmedetomidine 1Ileus 1Head and Neck Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1

Interventions

Fentanyl 1Dexmedetomidine 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Intrathecal Dexmedetomidine × Fentanyl × Clear all
NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown
60 enrolled
Other neoplasm

Intrathecal Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡